Response of PUVA-induced keratoses to etretinate

被引：8

作者：

HudsonPeacock, MJ

Angus, B

Farr, PM

机构：

[1] ROYAL VICTORIA INFIRM,DEPT DERMATOL,NEWCASTLE TYNE NE1 4LP,TYNE & WEAR,ENGLAND

[2] ROYAL VICTORIA INFIRM,DEPT PATHOL,NEWCASTLE TYNE NE1 4LP,TYNE & WEAR,ENGLAND

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 1996年 / 35卷 / 01期

关键词：

D O I：

10.1016/S0190-9622(96)90525-3

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：120 / 123

页数：4

共 8 条

[1]

BERRETTI B, 1983, RETINOID THERAPY REV, P187

[2] HIGH SINGLE-DOSE EUROPEAN PUVA REGIMEN ALSO CAUSES AN EXCESS OF NONMELANOMA SKIN-CANCER [J].

BRUYNZEEL, I ;

BERGMAN, W ;

HARTEVELT, HM ;

KENTER, CCA ;

VANDEVELDE, EA ;

SCHOTHORST, AA ;

SUURMOND, D .

BRITISH JOURNAL OF DERMATOLOGY, 1991, 124 (01) :49-55

[3] RETINOIDS TO PREVENT SKIN-CANCER IN ORGAN TRANSPLANT RECIPIENTS [J].

KELLY, JW ;

SABTO, J ;

GURR, FW ;

BRUCE, F .

LANCET, 1991, 338 (8779) :1407-1407

[4] PREVENTION OF SKIN-CANCER IN XERODERMA PIGMENTOSUM WITH THE USE OF ORAL ISOTRETINOIN [J].

KRAEMER, KH ;

DIGIOVANNA, JJ ;

MOSHELL, AN ;

TARONE, RE ;

PECK, GL .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (25) :1633-1637

[5]

LEVER LR, 1994, BRIT J DERMATOL, V131, P215

[6]

MORIARTY M, 1982, LANCET, V1, P364

[7]

SHUTTLEWORTH D, 1988, Q J MED, V68, P717

[8] NON-MELANOMA SKIN-CANCER OCCURRING IN PATIENTS TREATED WITH PUVA 5 TO 10 YEARS AFTER 1ST TREATMENT [J].

STERN, RS ;

LANGE, R .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1988, 91 (02) :120-124

← 1 →